As a result, the translation of these biomarker candidates to real-life application in a clinical setting has lagged far behind. Quantitative, targeted proteomics approaches, however, are now ...

Proteomics International Laboratories will launch its PromarkerEso oesophageal cancer test globally, backed by a top-tier ...

the only serum biomarker currently available in routine clinical practice for the diagnosis of biliary and pancreatic cancers, is lacking in specificity and sensitivity. Bile proteomics is ...

Oncology Consulting's Amy Cripps discusses the implications of proteomics in cancer research and the developing potential it presents.Castle ...

A precision medicine workflow integrating proteomics and personalized xenograft models was developed and applied to an ...

Distinguished, highly accomplished clinician with stellar track record of successfully leading numerous registrational trials ...

Why ALZpath, GeneDX, 10x Genomics, Protagonist Therapeutics, and Recursion are among the most innovative biotech companies of 2025.

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce the formation of ...

Proteomics International Laboratories’ OxiDx has secured an Australian patent for a finger-prick test to measure muscle ...